Literature DB >> 7495742

Gene-targeted B-deficient mice reveal a critical role for B cells in the CD4 T cell response.

Y Liu1, Y Wu, L Ramarathinam, Y Guo, D Huszar, M Trounstine, M Zhao.   

Abstract

The role of B cells in promoting T cell responses is still controversial. In this study, we use JHD mice which have a targeted mutation in the JH gene and are thus rendered deficient in B cells to address this issue. We show here that immunization of JHD mice with soluble antigen fails to prime CD4 T cells, for either clonal expansion or delivery of immunological help for antibody responses. This lack of CD4 T cell priming in JHD mice corresponds to a 3- to 9-fold lower co-stimulatory activity of antigen-presenting cells (APC) from the JHD mice, as measured by anti-CD3-induced proliferative responses of CD4 T cells. This in turn is due to a defect of APC from JHD mice in response to T cell-mediated induction of co-stimulatory activity. As the development of macrophages and dendritic cells is unaffected in the JHD mice, our results demonstrate that B cells play a critical role in CD4 T cell priming, possibly by delivering a critical co-stimulatory activity for clonal expansion of CD4 T cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7495742     DOI: 10.1093/intimm/7.8.1353

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  34 in total

1.  B cells and antibodies are required for resistance to the parasitic gastrointestinal nematode Trichuris muris.

Authors:  N M Blackwell; K J Else
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

2.  Endogenous antibodies promote rapid myelin clearance and effective axon regeneration after nerve injury.

Authors:  Mauricio E Vargas; Junryo Watanabe; Simar J Singh; William H Robinson; Ben A Barres
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-14       Impact factor: 11.205

3.  Interaction of the hepatitis B core antigen and the innate immune system.

Authors:  Byung O Lee; Amy Tucker; Lars Frelin; Matti Sallberg; Joyce Jones; Cory Peters; Janice Hughes; David Whitacre; Bryan Darsow; Darrell L Peterson; David R Milich
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

4.  Polarized helper-T-cell responses against Leishmania major in the absence of B cells.

Authors:  D R Brown; S L Reiner
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

5.  Proliferation of CD3+ B220- single-positive normal T cells was suppressed in B-cell-deficient lpr mice.

Authors:  T Akashi; S Nagafuchi; K Anzai; D Kitamura; J Wang; I Taniuchi; Y Niho; T Watanabe
Journal:  Immunology       Date:  1998-02       Impact factor: 7.397

Review 6.  The role of B cells and humoral immunity in Mycobacterium tuberculosis infection.

Authors:  John Chan; Simren Mehta; Sushma Bharrhan; Yong Chen; Jacqueline M Achkar; Arturo Casadevall; JoAnne Flynn
Journal:  Semin Immunol       Date:  2014-10-28       Impact factor: 11.130

7.  TLR and B cell receptor signals to B cells differentially program primary and memory Th1 responses to Salmonella enterica.

Authors:  Tom A Barr; Sheila Brown; Pietro Mastroeni; David Gray
Journal:  J Immunol       Date:  2010-07-30       Impact factor: 5.422

8.  Graft-versus-host disease: part I. Pathogenesis and clinical manifestations of graft-versus-host disease.

Authors:  Sharon R Hymes; Amin M Alousi; Edward W Cowen
Journal:  J Am Acad Dermatol       Date:  2012-04       Impact factor: 11.527

9.  Importance of B cell co-stimulation in CD4(+) T cell differentiation: X-linked agammaglobulinaemia, a human model.

Authors:  H Martini; V Enright; M Perro; S Workman; J Birmelin; E Giorda; I Quinti; V Lougaris; M Baronio; K Warnatz; B Grimbacher
Journal:  Clin Exp Immunol       Date:  2011-04-13       Impact factor: 4.330

10.  Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors.

Authors:  Katy Milne; Martin Köbel; Steven E Kalloger; Rebecca O Barnes; Dongxia Gao; C Blake Gilks; Peter H Watson; Brad H Nelson
Journal:  PLoS One       Date:  2009-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.